Loading clinical trials...
Loading clinical trials...
In this study, the progression of the disease and changes in quality of life will be examined over a 1-year follow-up period in groups of patients with Fibrosing Interstitial Lung Disease who either p...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Istanbul Medipol University Hospital
NCT07430943 · Pulmonary Rehabilitation, Physical Activities, and more
NCT05310669 · Fibrosis, Pulmonary
NCT07195838 · Mindfulness, Pulmonary Rehabilitation, and more
NCT07061444 · Hematopoietic Stem Cell Transplantation (HSCT), Pulmonary Rehabilitation, and more
NCT05604495 · Cystic Fibrosis, Pulmonary
Esra Pehli̇van
Istanbul, Üsküdar
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions